Company Search:
Advanced Search
Sponsored Links
Novartis AG - ADR Company Snapshot
Novartis AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novartis AG with three other companies in this sector in the United States: Pfizer Inc. (2018 sales of $53.65 billion of which 62% was Operating Segment-Global Innovative Phar), Bayer AG ($46.64 billion of which 42% was Pharmaceuticals & Biological Products), and Roche Holding Aktiengesellschaft ($58.19 billion of which 77% was Pharmaceuticals).

Sales Analysis. Novartis AG reported sales of $53.17 billion for the year ending December of 2018. This represents an increase of 6.0% versus 2017, when the company's sales were $50.14 billion. The sales level in 2018 was fairly close to the level five years ago: in 2013, Novartis AG had sales of $58.83 billion. Sales of Alcon saw an increase that was more than double the company's growth rate: sales were up 18.7% in 2018, from $6.02 billion to $7.15 billion. Not all segments of Novartis AG experienced an increase in sales in 2018: sales of Sandoz fell 2.0% to $9.86 billion.
  Stock Performance Chart for Novartis AG - ADR
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 90.04
(Figures in U.S. Dollars)
1 Week 1.9%   13 Weeks 3.6%  
4 Weeks 0.6%   52 Weeks 2.6%  
Novartis AG - ADR Key Data:
  Ticker: NVS Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 53,166,220,766
(Year Ending Jan 2019).
Employees: 125,161
  Currency: U.S. Dollars Market Cap: 203,905,314,314
  Fiscal Yr Ends: December Shares Outstanding: 2,264,608,111
  Share Type: Namenaktie Closely Held Shares: 90,915,965
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.